Decompressive hemicraniectomy
ProcedureDecompressive hemicraniectomy in the context of a malignat sylvian ischaemic cerebral accident
NCT Number: NCT04763161
The objective of the NEUTROSURGERY study is to describe the local and locoregional immuno-inflammatory activity in patients suffering from malignant sylvian ischaemic cerebral accident and treated with decompressive hemicraniectomy compared to a control population of patients to be operated on in neurosurgery for another neurosurgical pathology.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients:
Inclusion criteria
Control:
Non-inclusion Criteria Patients:
Non-inclusion Criteria Controls:
Decompressive hemicraniectomy in the context of a malignat sylvian ischaemic cerebral accident
neurosurgical operation on which cranial, meningeal, vascular (branch of the middle meningeal artery) or cerebral bone tissue is not preserved during the surgical approach.
Time frame: Day 0
Contact information is provided by the study sponsor or research team.
Amélie Dr YAVCHITZ, MD
CONTACT
01 48 03 64 54 ext. + 33
Benjamin MAIER, Professor, MD, PhD
CONTACT
01 48 03 72 13 ext. + 33
Fondation Ophtalmologique Adolphe de Rothschild
Network
Acronym: NEUTROSURGERY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07602400
Arterial Occlusive Diseases, Brain Diseases
View Trial DetailsNCT06700824
Brain Diseases, Cardiovascular Diseases
Bordeaux, France
View Trial DetailsNCT02523261
Brain Diseases, Cardiovascular Diseases
Bordeaux, France
View Trial DetailsNCT03570060
Brain Diseases, Cardiovascular Diseases
Dijon, France
View Trial Details